Researchers at Imperial College Healthcare NHS Trust have created an AI model which can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG).
The team from Imperial College…
As startups transition from initial proof-of-concept technology to a commercially viable product, they will have to face and navigate the “Death Valley” curve. This critical phase, marked by a high risk of failure, is…
Continue Reading
What You Should Know:
– Teladoc Health has announced the launch of new AI-powered capabilities for its Virtual Sitter solution.
– Virtual Sitter aims to enhance patient safety, address workforce challenges, and improve care delivery for…
Continue Reading
Urgent blood samples are being transported by electric drones at Guy’s and St Thomas’ NHS Foundation Trust, in a medical delivery service which aims to improve patient care by speeding up testing turnaround times.
The…
Electric drones will transport urgent blood samples in a six-month trial at Guy’s and St Thomas’ NHS Foundation Trust.
The medical delivery service, in partnership with healthcare logistics firm Apian and Alphabet’s global drone delivery…
We aimed to identify and characterise behavioural profiles in patients at high risk of SCD, by using deep representation learning of day-to-day behavioural recordings. We present a pipeline that employed unsupervised clustering on low-dimensional…
Continue Reading
A falls prevention app has been adopted by 37 care homes and 25 GP practices in Greater Manchester after a 12-month trial led to a 57% reduction in ambulance call-outs.
The Safe Steps app is…
Australia has one of the world’s highest levels of ultraviolet radiation, a proven carcinogen that causes skin care and eye diseases. UV damage is said to accumulate from childhood, and the risk of developing…
Continue Reading
What You Should Know:
– ColdVentures, a medical device innovator, has unveiled the ColdVest – a groundbreaking wearable technology designed to prevent heat stroke fatalities.
– The ColdVest is the first-of-its-kind, Class 1 FDA-approved portable emergency…
Continue Reading
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment of non-csPCa. Early identification…
Continue Reading
